Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association

on behalf of the American Heart Association Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Recent decades have witnessed robust successes in conquering the acutely lethal manifestations of heart and vascular diseases. Many patients who previously would have died now survive. Lifesaving successes like these provide a tremendous and easily recognized benefit to individuals and society. Although cardiovascular mortality has declined, the devastating impact of chronic heart disease and comorbidities on quality of life and healthcare resources continues unabated. Future strides, extending those made in recent decades, will require continued research into mechanisms underlying disease prevention, pathogenesis, progression, and therapeutic intervention. However, severe financial constraints currently jeopardize these efforts. To chart a path for the future, this report analyzes the challenges and opportunities we face in continuing the battle against cardiovascular disease and highlights the return on societal investment afforded by fundamental cardiovascular research.

Original languageEnglish (US)
JournalCirculation Research
DOIs
StateAccepted/In press - Jun 26 2017

Fingerprint

Heart Diseases
Quality of Health Care
Vascular Diseases
Research
Comorbidity
Chronic Disease
Cardiovascular Diseases
Quality of Life
Mortality
Therapeutics

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

on behalf of the American Heart Association Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council (Accepted/In press). Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association. Circulation Research. https://doi.org/10.1161/RES.0000000000000155

Fundamental Cardiovascular Research : Returns on Societal Investment: A Scientific Statement From the American Heart Association. / on behalf of the American Heart Association Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council.

In: Circulation Research, 26.06.2017.

Research output: Contribution to journalArticle

on behalf of the American Heart Association Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council 2017, 'Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association', Circulation Research. https://doi.org/10.1161/RES.0000000000000155
on behalf of the American Heart Association Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council. Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association. Circulation Research. 2017 Jun 26. https://doi.org/10.1161/RES.0000000000000155
on behalf of the American Heart Association Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council. / Fundamental Cardiovascular Research : Returns on Societal Investment: A Scientific Statement From the American Heart Association. In: Circulation Research. 2017.
@article{e4aca7dc2cc840b685d79f1b38144133,
title = "Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association",
abstract = "Recent decades have witnessed robust successes in conquering the acutely lethal manifestations of heart and vascular diseases. Many patients who previously would have died now survive. Lifesaving successes like these provide a tremendous and easily recognized benefit to individuals and society. Although cardiovascular mortality has declined, the devastating impact of chronic heart disease and comorbidities on quality of life and healthcare resources continues unabated. Future strides, extending those made in recent decades, will require continued research into mechanisms underlying disease prevention, pathogenesis, progression, and therapeutic intervention. However, severe financial constraints currently jeopardize these efforts. To chart a path for the future, this report analyzes the challenges and opportunities we face in continuing the battle against cardiovascular disease and highlights the return on societal investment afforded by fundamental cardiovascular research.",
author = "{on behalf of the American Heart Association Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council} and Hill, {Joseph A} and Reza Ardehali and Clarke, {Kimberli T} and {del Zoppo}, {Gregory J.} and Eckhardt, {Lee L.} and Griendling, {Kathy K.} and Peter Libby and Roden, {Dan M.} and Sadek, {Hesham A} and Seidman, {Christine E.} and Vaughan, {Douglas E.}",
year = "2017",
month = "6",
day = "26",
doi = "10.1161/RES.0000000000000155",
language = "English (US)",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Fundamental Cardiovascular Research

T2 - Returns on Societal Investment: A Scientific Statement From the American Heart Association

AU - on behalf of the American Heart Association Council on Basic Cardiovascular Sciences; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council

AU - Hill, Joseph A

AU - Ardehali, Reza

AU - Clarke, Kimberli T

AU - del Zoppo, Gregory J.

AU - Eckhardt, Lee L.

AU - Griendling, Kathy K.

AU - Libby, Peter

AU - Roden, Dan M.

AU - Sadek, Hesham A

AU - Seidman, Christine E.

AU - Vaughan, Douglas E.

PY - 2017/6/26

Y1 - 2017/6/26

N2 - Recent decades have witnessed robust successes in conquering the acutely lethal manifestations of heart and vascular diseases. Many patients who previously would have died now survive. Lifesaving successes like these provide a tremendous and easily recognized benefit to individuals and society. Although cardiovascular mortality has declined, the devastating impact of chronic heart disease and comorbidities on quality of life and healthcare resources continues unabated. Future strides, extending those made in recent decades, will require continued research into mechanisms underlying disease prevention, pathogenesis, progression, and therapeutic intervention. However, severe financial constraints currently jeopardize these efforts. To chart a path for the future, this report analyzes the challenges and opportunities we face in continuing the battle against cardiovascular disease and highlights the return on societal investment afforded by fundamental cardiovascular research.

AB - Recent decades have witnessed robust successes in conquering the acutely lethal manifestations of heart and vascular diseases. Many patients who previously would have died now survive. Lifesaving successes like these provide a tremendous and easily recognized benefit to individuals and society. Although cardiovascular mortality has declined, the devastating impact of chronic heart disease and comorbidities on quality of life and healthcare resources continues unabated. Future strides, extending those made in recent decades, will require continued research into mechanisms underlying disease prevention, pathogenesis, progression, and therapeutic intervention. However, severe financial constraints currently jeopardize these efforts. To chart a path for the future, this report analyzes the challenges and opportunities we face in continuing the battle against cardiovascular disease and highlights the return on societal investment afforded by fundamental cardiovascular research.

UR - http://www.scopus.com/inward/record.url?scp=85021278551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021278551&partnerID=8YFLogxK

U2 - 10.1161/RES.0000000000000155

DO - 10.1161/RES.0000000000000155

M3 - Article

C2 - 28652256

AN - SCOPUS:85021278551

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

ER -